FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Alembic Pharmaceuticals Diclofenac Sodium Topical Solution Recall

Diclofenac Sodium Topical Solution USP, 2% w/w, 3

ALEMBIC PHARMACEUTICALS, INC. · Bedminster, NJ

Risk level
Class II
Reported by FDA
Aug 2, 2023
Recall ID
D-0941-2023
Check your lot numberHow we source this data

Summary

Alembic Pharmaceuticals recalled Diclofenac Sodium Topical Solution starting Jun 22, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0941-2023 on Aug 2, 2023. Reason: Defective Delivery System. Status: Ongoing.

Why it was recalled

Defective Delivery System

Product description

Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Division) Karakhadi, Vadodara 391450, India. NDC 62332-487-12

Lot numbers, UPCs & expiration codes

Lot #: 220151, 220152, 220153, Exp. Date 11/2024

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0941-2023
Classification
Class II
Status
Ongoing
Recall initiated
Jun 22, 2023
FDA report date
Aug 2, 2023
Quantity
2844 units
Recall type
Voluntary: Firm initiated
Recalling firm
ALEMBIC PHARMACEUTICALS, INC.

Original FDA data

Every field from FDA enforcement report D-0941-2023, exactly as published.

Show all FDA fields
City
Bedminster
State
NJ
Status
Ongoing
Country
United States
Event ID
92581
Address
550 Hills Dr Ste 104b
Code information
Lot #: 220151, 220152, 220153, Exp. Date 11/2024
Postal code
07921-1537
Report date
Aug 2, 2023
Product type
Drugs
Recall number
D-0941-2023
Classification
Class II
Recalling firm
ALEMBIC PHARMACEUTICALS, INC.
Product quantity
2844 units
Reason for recall
Defective Delivery System
Voluntary / mandated
Voluntary: Firm initiated
Product description
Diclofenac Sodium Topical Solution USP, 2% w/w, 3.8 FL.OZ.(112 grams) bottles, Rx only, Manufactured for: Alembic Pharmaceuticals, Inc. Bedminster, NJ 07921, USA Manufactured by: Alembic Pharmaceuticals Limited (Derma Division) Karakhadi, Vadodara 391450, India. NDC 62332-487-12
Distribution pattern
Nationwide within the United States
Recall initiation date
Jun 22, 2023
Initial firm notification
Letter
Center classification date
Jul 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0941-2023, published Aug 2, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls